HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacology of acute effort angina.

Abstract
From the pharmacologic point of view, each of the major types of antianginal agents--calcium antagonists, beta-blockers, and nitrates--seem to act at least in part by an improvement of the myocardial blood supply. The recently elucidated mechanism of action of nitrates, acting on a common pathway with the endothelium-derived relaxation factor (EDRF), suggests an important role for guanylate cyclase and cyclic GMP in maintaining coronary artery patency in patients with coronary atheroma. The efficacy of calcium antagonists, even in effort-induced angina, is in accord with a current hypothesis that physical exercise in the presence of coronary stenosis can cause relative coronary vasoconstriction, or at the least, failure of full dilation. Therefore, calcium antagonists all act, at least in part, on the "supply" side of the supply-demand equation. Beta-adrenergic blockers appear to have as their major mode of action a reduction of heart rate, which not only reduces the oxygen demand but, through an anti-ischemic effect, also appears to improve the endocardial blood supply (in relation to the heart rate). Thus beta-blockade indirectly enhances the supply side of the equation. The intriguing situation arises whereby all three major types of antianginal compounds may also act by a common mechanism of anginal relief, namely, improvement in the coronary blood supply, in addition to the diverse mechanisms specific to each type of compound. That conclusion does not mean the the "demand" side of the equation can be ignored. Rather, the critical importance of a reduced myocardial blood supply in the production of anginal syndromes is highlighted.
AuthorsL H Opie
JournalCardiovascular drugs and therapy (Cardiovasc Drugs Ther) Vol. 3 Suppl 1 Pg. 257-70 (Jun 1989) ISSN: 0920-3206 [Print] United States
PMID2577296 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic beta-Antagonists
  • Calcium Channel Blockers
  • Nitrates
  • Vasoconstrictor Agents
  • Vasodilator Agents
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Angina Pectoris (drug therapy)
  • Animals
  • Calcium Channel Blockers (therapeutic use)
  • Coronary Circulation (drug effects)
  • Coronary Disease (metabolism)
  • Humans
  • Nitrates (therapeutic use)
  • Vasoconstrictor Agents (therapeutic use)
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: